CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 4 Planned sale Chief Executive Officer sold 525,991 shares at $0.95 ($499,691)
- 4 Planned sale Chief Executive Officer sold 525,991 shares at $1.12 ($589,110)
- 4 Open-market buy Chief Financial Officer bought 21,000 shares at $1.23 ($25,830)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 194,134 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 3,123,201 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 207,300 shares (grant or award)
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 1 of 15 · 288 filings